Profile
Mr. Timothy J.
Maines is a Chief Technical Operations & Quality Officer at Alnylam Pharmaceuticals, Inc. Mr. Maines was previously employed as a Vice President-Quality Assurance by ARIAD Pharmaceuticals, Inc., a Vice President-Quality by Omthera Pharmaceuticals, Inc., a Vice President-Corporate Quality by MedImmune LLC, a Vice President-Corporate Quality by rEVO Biologics, Inc., and a Director-Quality Assurance by Stryker Corp.
He received his undergraduate degree from Gannon University.
Timothy J. Maines active positions
| Companies | Position | Start |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/04/2023 |
Former positions of Timothy J. Maines
| Companies | Position | End |
|---|---|---|
| ARIAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/05/2017 |
| STRYKER CORPORATION | Corporate Officer/Principal | - |
Omthera Pharmaceuticals, Inc.
Omthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as pharmaceuticals company which focuses on the clinical development of new therapies for dyslipidemia | Corporate Officer/Principal | - |
| REVO BIOLOGICS INC | Corporate Officer/Principal | - |
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Corporate Officer/Principal | - |
Training of Timothy J. Maines
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Stryker Corp.
Stryker Corp. Medical SpecialtiesHealth Technology Manufactures and markets reconstructive, medical and surgical, and neurotechnology and spine products | Health Technology |
ARIAD Pharmaceuticals, Inc.
ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer | Health Technology |
Omthera Pharmaceuticals, Inc.
Omthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as pharmaceuticals company which focuses on the clinical development of new therapies for dyslipidemia | Health Technology |
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Gannon University
Gannon University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
rEVO Biologics, Inc.
rEVO Biologics, Inc. BiotechnologyHealth Technology Develops and commercializes specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions | Health Technology |
- Stock Market
- Insiders
- Timothy J. Maines
















